Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $46.1400 (0.47%) ($46.1400 - $46.1400) on Thu. Apr. 15, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.85% (three month average) | RSI | 78 | Latest Price | $46.1400(0.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.9% a day on average for past five trading days. | Weekly Trend | HALO advances 3.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(49%) IWO(49%) IWM(47%) IWC(43%) IWN(43%) | Factors Impacting HALO price | HALO will decline at least -1.425% in a week (0% probabilities). VIXM(-31%) VXX(-12%) UUP(-11%) IGOV(-3%) GLD(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.425% (StdDev 2.85%) | Hourly BBV | 0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $44.31(4.13%) | 10 Day Moving Average | $43.44(6.22%) | 20 Day Moving Average | $42.83(7.73%) | To recent high | -11.2% | To recent low | 16.6% | Market Cap | $6.306b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |